These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 8676820

  • 1. Lipoprotein(a) in patients with the nephrotic syndrome: influence of immunosuppression and proteinuria.
    Wanner C, Bartens W, Nauck M, Zäuner I, Greiber S, Schollmeyer P.
    Miner Electrolyte Metab; 1996; 22(1-3):26-30. PubMed ID: 8676820
    [Abstract] [Full Text] [Related]

  • 2. Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome.
    Wanner C, Rader D, Bartens W, Krämer J, Brewer HB, Schollmeyer P, Wieland H.
    Ann Intern Med; 1993 Aug 15; 119(4):263-9. PubMed ID: 8328733
    [Abstract] [Full Text] [Related]

  • 3. Effects of simvastatin on lipoprotein (a) and lipoprotein composition in patients with nephrotic syndrome.
    Wanner C, Böhler J, Eckardt HG, Wieland H, Schollmeyer P.
    Clin Nephrol; 1994 Mar 15; 41(3):138-43. PubMed ID: 8187355
    [Abstract] [Full Text] [Related]

  • 4. [Plasma Lp(a) levels: a comparison between diabetic and nondiabetic patients with the nephrotic syndrome and control subjects].
    Postorino G, Altavilla R, Turchetti V, De Matteis C, Leoncini F, Picciolini F, Guerrini M, Forconi S.
    Recenti Prog Med; 1995 Feb 15; 86(2):53-6. PubMed ID: 7754172
    [Abstract] [Full Text] [Related]

  • 5. Protein loss and genetic polymorphism of apolipoprotein(a) modulate serum lipoprotein(a) in CAPD patients.
    Wanner C, Bartens W, Walz G, Nauck M, Schollmeyer P.
    Nephrol Dial Transplant; 1995 Feb 15; 10(1):75-81. PubMed ID: 7724034
    [Abstract] [Full Text] [Related]

  • 6. Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production.
    Rader DJ, Cain W, Zech LA, Usher D, Brewer HB.
    J Clin Invest; 1993 Feb 15; 91(2):443-7. PubMed ID: 8432853
    [Abstract] [Full Text] [Related]

  • 7. Lipoprotein(a) serum levels and apolipoprotein(a) phenotypes in children with chronic renal disease.
    Querfeld U, Lang M, Friedrich JB, Kohl B, Fiehn W, Schärer K.
    Pediatr Res; 1993 Dec 15; 34(6):772-6. PubMed ID: 8108191
    [Abstract] [Full Text] [Related]

  • 8. Lipoprotein profiles in a heterogeneous group of patients with nephrotic syndrome.
    Michaeli J, Bar-On H, Shafrir E.
    Isr J Med Sci; 1981 Nov 15; 17(11):1001-8. PubMed ID: 7319786
    [Abstract] [Full Text] [Related]

  • 9. Symptomatic antiproteinuric treatment decreases serum lipoprotein (a) concentration in patients with glomerular proteinuria.
    Gansevoort RT, Heeg JE, Dikkeschei FD, de Zeeuw D, de Jong PE, Dullaart RP.
    Nephrol Dial Transplant; 1994 Nov 15; 9(3):244-50. PubMed ID: 8052429
    [Abstract] [Full Text] [Related]

  • 10. [Lp(a) serum concentrations in diabetes mellitus].
    Murakami J, Kumasaka K, Kawano K, Murakami T, Hayashi Y, Arakawa Y.
    Rinsho Byori; 1994 Dec 15; 42(12):1273-8. PubMed ID: 7869592
    [Abstract] [Full Text] [Related]

  • 11. Analyses of serum lipoprotein(a) and the relation to phenotypes and genotypes of apolipoprotein(a) in type 2 diabetic patients with retinopathy.
    Suehiro M, Ohkubo K, Kato H, Kido Y, Anzai K, Oshima K, Ono J.
    Exp Clin Endocrinol Diabetes; 2002 Oct 15; 110(7):319-24. PubMed ID: 12397529
    [Abstract] [Full Text] [Related]

  • 12. Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus.
    Murase T, Okubo M, Amemiya-Kudo M, Ebara T, Mori Y.
    Metabolism; 2008 Jun 15; 57(6):791-5. PubMed ID: 18502261
    [Abstract] [Full Text] [Related]

  • 13. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).
    Dieplinger H, Lackner C, Kronenberg F, Sandholzer C, Lhotta K, Hoppichler F, Graf H, König P.
    J Clin Invest; 1993 Feb 15; 91(2):397-401. PubMed ID: 8432847
    [Abstract] [Full Text] [Related]

  • 14. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
    Gaeta G, Cuomo S, Capozzi G, Foglia MC, Barra S, Madrid A, Stornaiuolo V, Trevisan M.
    Nutr Metab Cardiovasc Dis; 2008 Sep 15; 18(7):492-6. PubMed ID: 17962002
    [Abstract] [Full Text] [Related]

  • 15. Determination of lipoprotein(a) concentrations and apolipoprotein(a) molecular weights in diabetic patients.
    Ribault A, Durou MR, Letellier C, Wojcik F, Poirier JY, Ruelland A.
    Diabetes Metab; 2000 Apr 15; 26(2):107-12. PubMed ID: 10804324
    [Abstract] [Full Text] [Related]

  • 16. High risk levels of lipoprotein(a) in Pakistani patients with type 2 diabetes mellitus.
    Habib SS, Aslam M.
    Saudi Med J; 2003 Jun 15; 24(6):647-51. PubMed ID: 12847596
    [Abstract] [Full Text] [Related]

  • 17. Elevated lipoprotein (a) levels in primary nephrotic syndrome.
    Faucher C, Doucet C, Baumelou A, Chapman J, Jacobs C, Thillet J.
    Am J Kidney Dis; 1993 Dec 15; 22(6):808-13. PubMed ID: 8250027
    [Abstract] [Full Text] [Related]

  • 18. Lipoprotein(a) in nephrotic syndrome and end-stage renal disease.
    Greiber S, Wanner C.
    Miner Electrolyte Metab; 1997 Dec 15; 23(3-6):161-5. PubMed ID: 9387108
    [Abstract] [Full Text] [Related]

  • 19. Plasma lipoprotein (a) levels in children with minimal lesion nephrotic syndrome.
    Nakahara C, Kobayashi K, Hamaguchi H, Kanemoto K, Kashiwagi R, Matsui A.
    Pediatr Nephrol; 1999 Oct 15; 13(8):657-61. PubMed ID: 10502122
    [Abstract] [Full Text] [Related]

  • 20. Lipoprotein(a) concentrations in patients with type 2 diabetes mellitus without cardiovascular disease: relationship to metabolic parameters and diabetic complications.
    Tarkun I, Cetinarslan B, Cantürk Z.
    Nutr Metab Cardiovasc Dis; 2002 Jun 15; 12(3):127-31. PubMed ID: 12325469
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.